Gezim Lahu - Info zur Person mit Bilder, News & Links



	Biomarker Pharmacokinetics Population Roflumilast and Roflumilast Thomas

News

MEDICAL TRIBUNE CZ > Roflumilast od A do Z

www.tribune.cz

Informační portál nakladatelství MEDICAL TRIBUNE CZ, s.r.o. určeny odborníkům pracujícím ve zdravotnictví. Najdete zde obsahy titulů, aktuality, dokumenty,...

Interessen

LandOfFree - Inventor - Gezim Lahu

canadianpatents.landoffree.com

Check out Gezim Lahu. Rate and share your experience with other people.

Bücher

(1 - 4 von 7

–alle anzeigen

)

Repeatability of and relationship between potential COPD biomarkers...

doaj.org

Information about the open-access article 'Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies,...

authors:"Gezim Lahu" - Search | Paperity

paperity.org

Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place

Phosphodiesterases as Drug Targets - Google Books

books.google.de

Impact. of. Human. Pharmacokinetics. Hermann Tenor, Armin Hatzelmann, Rolf Beume, Gezim Lahu, Karl Zech, and Thomas D. Bethke Contents 1 Introduction .

Gezim Lahu | XanEdu Customization Platform

www.academicpub.com

Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibody.

Dokumente zum Namen

Welcome to the Population Approach Group in Europe

www.page-meeting.org

Axel Facius (1), Laurent Claret (2), Rene Bruno (2), Gezim Lahu (1), Dirk Bredenbröker (1) (1) Department of PKPD and Biomarker Sciences, Nycomed GmbH, Konstanz, Germany

Wissenschaftliche Veröffentlichungen

KOPS.Multi-response model for rheumatoid arthritis based on delay...

kops.uni-konstanz.de

KOCH, Gilbert, Thomas WAGNER, Christine PLATER-ZYBERK, Gezim LAHU, Johannes SCHROPP, Multi ...

Gezim Lahu – ScienceOpen

www.scienceopen.com

Combination therapies are widely used in the treatment of patients with cancer. Selecting synergistic combination strategies is a great challenge during early ...

Veröffentlichungen allgemein

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast...

link.springer.com

... Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model. Authors; Authors and affiliations. Gezim Lahu Email author ...

No relevant cardiac, pharmacokinetic or safety interactions between...

link.springer.com

Christian de Mey · (1); Nassr Nassr · (2); Gezim Lahu · ...

Steady-State Pharmacokinetics of Roflumilast and Roflumilast N -Oxide...

link.springer.com

Robert Hermann,1 Nassr Nassr,1 Gezim Lahu,2 ´Eva Péterfai,3 Dietrich Knoerzer,2. Rolf Herzog,4 Karl Zech5 and Christian de Mey6. 1 Exploratory Medicine ...

Artikel & Meinungen

| Nature Careers

www.nature.com

Elizabeth Harrington, Director, Translational Science Oncology, AstraZeneca -Gezim Lahu, Senior Director Global Head of Pharmacometrics,

Sonstiges

Gezim Lahu | LinkedIn

www.linkedin.com

View Gezim Lahu's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Gezim Lahu discover inside ...

Mr Gezim Lahu | Exploratory 2016

www.terrapinn.com

Mr Gezim Lahu - Europe’s largest and most influential early development / phase I congress

HUM-MOLGEN events: 12th Annual Biomarkers Congress

hum-molgen.org

central resource for events in human genetics and molecular biology

Acute treatment with the PDE4 inhibitor roflumilast improves verbal...

cris.maastrichtuniversity.nl

author = "Arjan Blokland and {Van Duinen}, {Marlies A.} and Anke Sambeth and Heckman, {Pim R.A.} and Max Tsai and Gezim Lahu and Tolga Uz and Jos ...

Chronic Obstructive Pulmonary Disease: Lahu, Gezim - Expertscape.com

www.expertscape.com

Medical and scientific articles about Pulmonary Disease, Chronic Obstructive, written by Gezim Lahu

Constant-load exercise decreases the serum concentration of...

www.dovepress.com

Olaf Holz,1,* Stefan Roepcke,2,* Henrik Watz,3 Uwe Tegtbur,4Gezim Lahu,2 Jens M Hohlfeld1 1Fraunhofer Institute for Toxicology and ...

Lack of a pharmacokinetic interaction between steady-state...

www.bps.ac.uk

Our journals promote pharmacology in all its forms by disseminating the latest high quality research in our peer reviewed scientific journals.

Day 1 | Exploratory 2016

www.terrapinn.com

Day 1 - Europe’s largest and most influential early development / phase I congress

InScope : : Issues: InScope: Indiana University

inscope.medicine.iu.edu

10, at Hine Hall on the IUPUI campus, 875 North St., Room This two-day program will feature speakers from academia, industry and regulatory agencies, including Robert Bies (University at Buffalo), Sean Mooney (University of Washington), Gezim Lahu (Takeda), Anna Georgieva Kondic (Merck) and ...

Model-Based Approach to Predict Adherence to Protocol During...

www.growkudos.com

Model-Based Approach to Predict Adherence to Protocol During Antiobesity Trials. Vishnu D. Sharma, François P. Combes, Majid Vakilynejad, Gezim Lahu, Lawrence J. Lesko, Mirjam N. Trame. The Journal of Clinical Pharmacology, August 2017, Wiley; DOI: jcph Welcome to the new Kudos publication page.

Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are...

read.qxmd.com

Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent. Hans G Kress, Hildegard Boss, Thomas Delvin, Gezim Lahu, Søren ...

Modeling of tumor growth and anticancer effects of combination...

www.bionity.com

Combination therapies are widely used in the treatment of patients with cancer. Selecting synergistic combination strategies is a great challenge during early...

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast...

www.growkudos.com

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model. Gezim Lahu, Andreas Hünnemeyer, Edgar Diletti, Martin Elmlinger, Peter Ruth, Karl Zech, Nigel McCracken, Axel ...

PLOS ONE: Repeatability of and Relationship between Potential COPD...

journals.plos.org

Gezim Lahu,. Affiliation Department of Biomarker Development, Nycomed GmbH, Konstanz, Germany. ⨯. Martin Elmlinger,. Affiliation Department of Biomarker ...